These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22238390)

  • 21. Maternal and fetal cord blood lipids in intrauterine growth restriction.
    Pecks U; Brieger M; Schiessl B; Bauerschlag DO; Piroth D; Bruno B; Fitzner C; Orlikowsky T; Maass N; Rath W
    J Perinat Med; 2012 Jan; 40(3):287-96. PubMed ID: 22505508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fetal growth restriction and insulin resistance. New findings and review of the literature].
    Soto I N; Mericq G V
    Rev Med Chil; 2005 Jan; 133(1):97-104. PubMed ID: 15768156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive function in young adults following intrauterine growth restriction with abnormal fetal aortic blood flow.
    Tideman E; Marsál K; Ley D
    Ultrasound Obstet Gynecol; 2007 Jun; 29(6):614-8. PubMed ID: 17523158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: Placental programming of postnatal diabetes and impaired insulin action after IUGR.
    Gatford KL; Simmons RA; De Blasio MJ; Robinson JS; Owens JA
    Placenta; 2010 Mar; 31 Suppl(0):S60-5. PubMed ID: 20096455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fetal programming of type 2 diabetes--intrauterine growth retardation (IUGR) as risk factor?].
    Eberle C
    MMW Fortschr Med; 2010 Oct; 152 Suppl 3():76-82. PubMed ID: 21595150
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of fetal and neonatal growth curves in detecting growth restriction.
    Marconi AM; Ronzoni S; Bozzetti P; Vailati S; Morabito A; Battaglia FC
    Obstet Gynecol; 2008 Dec; 112(6):1227-1234. PubMed ID: 19037030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome.
    Valsamakis G; Kanaka-Gantenbein C; Malamitsi-Puchner A; Mastorakos G
    Ann N Y Acad Sci; 2006 Dec; 1092():138-47. PubMed ID: 17308140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small for gestational age and the metabolic syndrome: which mechanism is suggested by epidemiological and clinical studies?
    Lévy-Marchal C; Czernichow P
    Horm Res; 2006; 65 Suppl 3():123-30. PubMed ID: 16612125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrauterine growth restriction results in persistent vascular mismatch in adulthood.
    Kuo AH; Li C; Huber HF; Clarke GD; Nathanielsz PW
    J Physiol; 2018 Dec; 596(23):5777-5790. PubMed ID: 29098705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highlighting the trajectory from intrauterine growth restriction to future obesity.
    Gantenbein KV; Kanaka-Gantenbein C
    Front Endocrinol (Lausanne); 2022; 13():1041718. PubMed ID: 36440208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consequences of intrauterine growth and early neonatal catch-up growth.
    Claris O; Beltrand J; Levy-Marchal C
    Semin Perinatol; 2010 Jun; 34(3):207-10. PubMed ID: 20494737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intrauterine growth restriction phenotype: fetal adaptations and potential implications for later life insulin resistance and diabetes.
    Thorn SR; Rozance PJ; Brown LD; Hay WW
    Semin Reprod Med; 2011 May; 29(3):225-36. PubMed ID: 21710398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrauterine Growth Restriction (IUGR) Induces Signs of Subclinical Atherosclerosis in 6-Year-Old Infants Despite Absence Of Excessive Growth.
    Tzschoppe A; von Kries R; Struwe E; Rascher W; Dörr HG; Jüngert J; Rauh M; Beckmann M; Schild R; Goecke TW; Dötsch J
    Klin Padiatr; 2017 Jul; 229(4):209-215. PubMed ID: 28718186
    [No Abstract]   [Full Text] [Related]  

  • 34. Consequences of a compromised intrauterine environment on islet function.
    Green AS; Rozance PJ; Limesand SW
    J Endocrinol; 2010 Jun; 205(3):211-24. PubMed ID: 20223861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term circulatory and renal consequences of intrauterine growth restriction.
    Simeoni U; Zetterström R
    Acta Paediatr; 2005 Jul; 94(7):819-24. PubMed ID: 16188798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal origins of insulin resistance and the metabolic syndrome: a key role for adipose tissue?
    Meas T
    Diabetes Metab; 2010 Feb; 36(1):11-20. PubMed ID: 19815442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small for gestational age: short stature and beyond.
    Saenger P; Czernichow P; Hughes I; Reiter EO
    Endocr Rev; 2007 Apr; 28(2):219-51. PubMed ID: 17322454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine-related causes and consequences of intrauterine growth retardation.
    Kanaka-Gantenbein C; Mastorakos G; Chrousos GP
    Ann N Y Acad Sci; 2003 Nov; 997():150-7. PubMed ID: 14644821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The thrifty 'catch-up fat' phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome.
    Dulloo AG; Jacquet J; Seydoux J; Montani JP
    Int J Obes (Lond); 2006 Dec; 30 Suppl 4():S23-35. PubMed ID: 17133232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular function in children born very preterm after intrauterine growth restriction with severely abnormal umbilical artery blood flow.
    Morsing E; Liuba P; Fellman V; Maršál K; Brodszki J
    Eur J Prev Cardiol; 2014 Oct; 21(10):1257-66. PubMed ID: 23613223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.